Skip to search formSkip to main contentSkip to account menu

PGRMC1 wt Allele

Known as: HPR6.6, MPR, Progesterone Receptor Membrane Component 1 wt Allele 
Human PGRMC1 wild-type allele is located within Xq22-q24 and is approximately 8 kb in length. This allele, which encodes membrane-associated… 
National Institutes of Health

Related topics

Related topics

4 relations
Ligand BindingLipid BindingPGRMC1 genePGRMC1 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Development of a process to improve medication adherence in patients with rheumatoid arthritis in the specialty pharmacy setting.
2019
2019
TMEM 97 and PGRMC 1 do not mediate sigma-2 ligand-induced cell death
Sigma-2 receptors have been implicated in both tumor proliferation and neurodegenerative diseases. Recently the sigma-2 receptor… 
2018
2018
Proteomic profile associated with cell death induced by androgens in Taenia crassiceps cysticerci: proposed interactome
Abstract Androgens have been shown to exert a cysticidal effect upon Taenia crassiceps, an experimental model of cysticercosis… 
2018
2018
Simulation Analysis of OLSR and Its Variant with Cooperative MPR Selection on NS-2.35 in Mobile Ad-Hoc Networks
Mobile Ad-Hoc networks (MANETs) can be classified as Decentralized, Independent and SelfOrganizing dynamic networks of… 
2017
2017
Expression of PGRMC1 in paraffin-embedded tissues of breast cancer.
Hormone replacement therapy (HRT) can increase the risk of breast cancer, shown especially in the only double-blind placebo… 
2016
2016
Optimal MPR Set Selection Algorithm Based on OLSR Routing Protocol
The optimal MPR (Multi Point Relay) set selection algorithm is proposed based on the researches of the OLSR (Optimized Link State… 
2016
2016
High expression level of PGRMC 1 correlates to clinicopathological characteristics in patients with lung adenocarcinoma
Previous studies in several cancer types have shown that up-regulation of progesterone receptor membrane component 1 (PGRMC1) was… 
2015
2015
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.
BACKGROUND Through reduced out-of-pocket costs and wellness offerings, value-based benefit design (VBBD) is a promising strategy… 
2012
2012
Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
Objective: To evaluate the medication adherence of individuals participating in a pharmacist-run employee health Cardiovascular… 
2010
2010
rogesterone inhibits apoptosis in part by PGRMC 1-regulated gene expression
Progesterone receptor membrane component-1 (PGRMC1) is present in both the cytoplasm and nucleus of spontaneously immortalized… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)